Topics

Medicrea Reports 2018 Fourth Quarter and Annual Sales Confirmation of Strong Growth Momentum

03:24 EST 16 Jan 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Fourth quarter sales: +30% (at constant exchange rate)Annual sales: +22% (at constant exchange rate)Fourth quarter UNiD ASI ™ personalized surgeries in the US: + 94% The Medicrea Group (Euronext Growth Paris: FR0...

Other Sources for this Article

Medicrea
Denys SOURNAC
Founder, Chairman and CEO
dsournac@medicrea.com

Fabrice KILFIGER
Chief Financial Officer
fkilfiger@medicrea.com
Tel: +33 (0)4 72 01 87 87

NEXT ARTICLE

More From BioPortfolio on "Medicrea Reports 2018 Fourth Quarter and Annual Sales Confirmation of Strong Growth Momentum"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...